Campbell & Co Investment Adviser’s KalVista Pharmaceuticals KALV Stock Holding History

Campbell & Co Investment Adviser’s Portfolio KALV Stock Details KALV Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.29M	Buy
2024 Q3	–	Sell
2024 Q2	$301K	Buy
2024 Q1	$119K	Sell
2023 Q4	$507K	Buy